Treatment of IgA nephropathy
- 1 March 1999
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 353 (9156) , 860-862
- https://doi.org/10.1016/s0140-6736(98)00395-x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathyClinical and Experimental Immunology, 1995
- Effect of Angiotensin-Converting Enzyme and Calcium Channel Inhibition on Progression of IgA NephropathyPublished by S. Karger AG ,1995
- Long-term Benefits of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Severe Immunoglobulin A Nephropathy: A Comparison to Patients Receiving Treatment With Other Antihypertensive Agents and to Patients Receiving No TherapyAmerican Journal of Kidney Diseases, 1994
- Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisonePediatric Nephrology, 1993
- Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritisThe Journal of Pediatrics, 1992
- Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathyKidney International, 1991
- Meta-Analysis of Randomised Controlled Trials in Patients with Primary IgA Nephropathy (Berger's Disease)Nephrology Dialysis Transplantation, 1990
- Moderately Proteinuric IgA Nephropathy: Prognostic Prediction of Individual Clinical Courses and Steroid Therapy in Progressive CasesNephron, 1989
- Prognostic Pathologic Markers in IgA NephropathyAmerican Journal of Kidney Diseases, 1988
- Steroid Therapy in IgA Nephropathy: A Retrospective Study in Heavy Proteinuric CasesNephron, 1988